LeMaitre Vascular, Inc.
LMAT
$92.34
-$4.25-4.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.55M | 64.45M | 61.05M | 64.23M | 59.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.55M | 64.45M | 61.05M | 64.23M | 59.87M |
| Cost of Revenue | 18.16M | 18.26M | 17.79M | 19.26M | 18.45M |
| Gross Profit | 48.40M | 46.19M | 43.26M | 44.97M | 41.42M |
| SG&A Expenses | 26.56M | 23.83M | 24.47M | 25.29M | 24.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.78M | 45.62M | 45.53M | 48.09M | 47.25M |
| Operating Income | 17.78M | 18.83M | 15.51M | 16.14M | 12.63M |
| Income Before Tax | 19.67M | 20.30M | 22.57M | 18.07M | 14.24M |
| Income Tax Expenses | 3.99M | 4.72M | 5.21M | 4.29M | 3.23M |
| Earnings from Continuing Operations | 15.68M | 15.58M | 17.36M | 13.78M | 11.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.68M | 15.58M | 17.36M | 13.78M | 11.01M |
| EBIT | 17.78M | 18.83M | 15.51M | 16.14M | 12.63M |
| EBITDA | 20.40M | 21.44M | 18.13M | 18.79M | 15.18M |
| EPS Basic | 0.69 | 0.69 | 0.77 | 0.61 | 0.49 |
| Normalized Basic EPS | 0.54 | 0.57 | 0.49 | 0.50 | 0.39 |
| EPS Diluted | 0.68 | 0.68 | 0.75 | 0.60 | 0.48 |
| Normalized Diluted EPS | 0.53 | 0.57 | 0.46 | 0.49 | 0.39 |
| Average Basic Shares Outstanding | 22.80M | 22.71M | 22.66M | 22.61M | 22.57M |
| Average Diluted Shares Outstanding | 23.03M | 22.97M | 24.39M | 22.89M | 22.90M |
| Dividend Per Share | 0.25 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 36.42% | 29.12% | 26.12% | 32.80% | 41.02% |